Cargando…

17. Comparative Assessment of a Machine Learning Model and Rectal Swab Surveillance to Predict Hospital Onset Clostridioides difficile

BACKGROUND: Hospital onset Clostridioides difficile infection (HO-CDI) is associated with significant morbidity and mortality. Screening individuals at risk could help limit transmission, however swab-based surveillance for HO-CDI is resource intensive. Applied to electronic health records (EHR) dat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ötleş, Erkin, Oh, Jeeheh, Patel, Alieysa, Keidan, Micah, Young, Vincent B, Rao, Krishna, Wiens, Jenna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Oral Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644772/ http://dx.doi.org/10.1093/ofid/ofab466.017

Ejemplares similares

Clostridioides difficile infection surveillance in intensive care units and oncology wards using machine learning
por: Ötleş, Erkin, et al.
Publicado: (2023)

Using Machine Learning and the Electronic Health Record to Predict Complicated Clostridium difficile Infection
por: Li, Benjamin Y, et al.
Publicado: (2019)

Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit
por: Miles-Jay, Arianna, et al.
Publicado: (2023)

691. Association between Clostridioides difficile Colonization, Rectal Swab NAAT Positivity, and Environmental Contamination
por: Lee, Mary Morgan, et al.
Publicado: (2023)

18. Global Surveillance of Clostridioides difficile Demonstrates High Prevalence in Non-Healthcare Settings
por: Jo, Jinhee, et al.
Publicado: (2021)

Proton Pump Inhibitor-Induced Gut Dysbiosis Increases Mortality Rates for Patients with Clostridioides difficile Infection
por: Lin, Cheng-Yu, et al.
Publicado: (2022)

Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection
por: Dieterle, Michael G., et al.
Publicado: (2020)

Clostridioides difficile toxin is infrequently detected in inflammatory bowel disease and does not associate with clinical outcomes
por: Bernard, Rachel, et al.
Publicado: (2022)

A12 STEPWISE COORDINATION OF COLONIC NEUTROPHILS AND INNATE LYMPHOID CELLS IN THE ONSET AND RESOLUTION OF CLOSTRIDIOIDES DIFFICILE TOXIN-INDUCED INJURY
por: Flannigan, K L, et al.
Publicado: (2022)

The accuracy of fully automated algorithms for surveillance of healthcare-onset Clostridioides difficile infections in hospitalized patients
por: van der Werff, Suzanne Desirée, et al.
Publicado: (2022)

54101 Characterizing Microbiota Features of Clostridioides difficile Infections
por: Tomkovich, Sarah, et al.
Publicado: (2021)

791. Evaluation of NSAID Exposure as a Risk Factor for Clostridium difficile infection: A Propensity-Score-Matched Case-Control Study
por: Ressler, Adam M, et al.
Publicado: (2020)

National Surveillance for Clostridioides difficile Infection, Sweden, 2009–2016
por: Rizzardi, Kristina, et al.
Publicado: (2018)

Impact of a training program on the surveillance of Clostridioides difficile infection
por: Sopena, N., et al.
Publicado: (2019)

Clostridioides difficile in national food surveillance, Slovenia, 2015 to 2017
por: Tkalec, Valerija, et al.
Publicado: (2020)

Sentinel surveillance and epidemiology of Clostridioides difficile in Denmark, 2016 to 2019
por: Persson, Søren, et al.
Publicado: (2022)

2236. Stool-Derived Inflammatory Mediators Serve as Biomarkers of Severity in Clostridium difficile Infection
por: Motyka, Jonathan, et al.
Publicado: (2019)

Community-Onset Clostridioides Difficile Infection in Hospitalized Patients in The Netherlands
por: Crobach, M J T, et al.
Publicado: (2019)

Nurse Work Environment and Hospital-Onset Clostridioides difficile Infection
por: Jung, Olivia S., et al.
Publicado: (2023)

2403. Clostridium difficile ribotypes and human microbiota differ in Taiwan and the United States with respect to diarrheal patients
por: Motyka, Jonathan, et al.
Publicado: (2019)

16. Attributable Mortality, Healthcare Costs and Out-of-Pocket Costs of Clostridioides difficile Infection in US Medicare Advantage Enrollees
por: Yu, Holly, et al.
Publicado: (2021)

The cytotoxic synergy between Clostridioides difficile toxin B and proinflammatory cytokines: an unholy alliance favoring the onset of Clostridioides difficile infection and relapses
por: Bassotti, Gabrio, et al.
Publicado: (2020)

2413. Assessment of compliance with Clostridioides difficile prophylaxis guideline and its efficacy on secondary prophylaxis and reducing hospital-onset Clostridioides difficile infections.
por: Vyas, Nikunj M, et al.
Publicado: (2019)

2355. The Association Between Diagnostic Testing Method and Clostridium difficile Infection Severity
por: Menon, Anitha, et al.
Publicado: (2019)

2424. Shedding of Viable Clostridiodes difficile in Patients Admitted to a Medical Intensive Care Unit
por: Young, Vincent B, et al.
Publicado: (2019)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

Hospital-onset Clostridioides difficile infections during the COVID-19 pandemic
por: Luo, Yuying, et al.
Publicado: (2020)

687. Zinplava Expert Retrospective Observations (ZERO) Study Findings on Clostridioides difficile Recurrence
por: Jacobs, Micah, et al.
Publicado: (2023)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

The Effect of a Clinical Pathway on Reducing the Rate of Healthcare-Onset Clostridioides difficile
por: Millard, John W., et al.
Publicado: (2020)

Impacts of Corticosteroid Therapy at Acute Stage of Hospital-Onset Clostridioides difficile Infections
por: Lee, Ching-Chi, et al.
Publicado: (2022)

Role of diagnostic stewardship in reducing healthcare facility-onset Clostridioides difficile infections
por: Shallal, Anita, et al.
Publicado: (2022)

Role of diagnostic stewardship in reducing healthcare-facility–onset Clostridioides difficile infections
por: Shallal, Anita B., et al.
Publicado: (2023)

1203. Impact of Antimicrobial Stewardship Interventions on Hospital-Onset Clostridioides difficile Infections
por: Kwon, Taesung, et al.
Publicado: (2023)

Patient Perception of Route of Rectal Administration of Live Biotherapeutic Product for Recurrent Clostridioides difficile Infection
por: Feuerstadt, Paul, et al.
Publicado: (2023)

2409. External Validation and Comparison of Clostridioides difficile Severity Scoring Systems
por: Perry, Donald A, et al.
Publicado: (2019)

129. Antimicrobial Resistance Genes Were Reduced Following Administration of Investigational Microbiota-Based Live Biotherapeutic RBX2660 to Individuals with Recurrent Clostridioides difficile Infection
por: Hau, Heidi, et al.
Publicado: (2021)

167. Efficacy of Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Individuals with Recurrent Clostridioides difficile Infection: Data from Five Prospective Clinical Studies
por: Bancke, Lindy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7ll883t8at7c7h4tsuvvhd2cag